Genpact Limited
NYSE:GInformation Technology Services
-$2.73 today
- Market cap
- $7.12B
- Beta
- 0.59
- P/E (TTM)
- 8.2
- EPS (TTM)
- $3.34
- Dividend yield
- 2.59%
Volume 2.37M
Average 2.81M
G Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Genpact LimitedNYSE: G
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables turns positive
Q3 FY2026 accounts payables was $8.57M, compared with -$9.8M a year earlier. Trailing-twelve-month accounts payables was -$9.71M.
Context
- Accounts payables amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near $8.57M or moves back toward the trailing-twelve-month quarterly average of -$2.43M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (6.42M) USD
- Year-over-year change
- -173.5%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (6.42M) | -173.5% |
| FY2024 | 2024-12-31 | 8.73M | +206.3% |
| FY2023 | 2023-12-31 | (8.22M) | -157.9% |
| FY2022 | 2022-12-31 | 14.19M | +20.8% |
| FY2021 | 2021-12-31 | 11.74M | — |
Accounts Payables vs competitors
How G compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -158.8% is the 10th highest of 11, against a peer median of +19.8%.
- Accounts payables amounts to 0.2% of revenue for G, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $13.91B USD | +225.1% | +86.2% | 38.7% | |
INGMIngram Micro Holding Corporation | LTM Jun 2026 | $1.89B USD | +71.9% | +69.7% | 3.4% |
| LTM Jun 2026 | $144M USD | -39.0% | — | 0.5% | |
| LTM Jun 2026 | $111.13M USD | +245.7% | — | 8.2% | |
| LTM Jun 2026 | $72.5M USD | -1494.2% | — | 1.5% | |
| LTM Jul 2026 | $43M USD | +155.8% | +123.9% | 0.6% | |
| LTM Jun 2026 | $18.31M USD | +256.6% | — | 0.9% | |
| LTM Jun 2026 | $11.82M USD | -32.2% | — | 1.0% | |
| LTM Jun 2026 | $10.63M USD | -64.2% | +67.6% | 0.5% | |
| LTM Sep 2026 | $9.71M USD | -158.8% | — | 0.2% | |
| LTM Jun 2026 | CN¥0 CNY | -100.0% | -69.4% | 0.0% | |
| Peer median (excluding G) | — | +19.8% | +69.7% | 0.9% | |
Competitors are the stored peer set for G. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 369.45M | 353.4M | 631.26M | 513.67M | 552.49M |
| Depreciation & Amortization | 167.57M | 129.52M | 103.99M | 69.78M | 94.96M |
| Deferred Income Tax | (9.26M) | (29.15M) | (157.93M) | 36.61M | 19.94M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 89.62M |
| Change in Working Capital | 87.16M | (147.08M) | (182.24M) | (100.18M) | 17.89M |
| Accounts Receivables | (11.8M) | (112.34M) | (130.79M) | (96.56M) | (44.22M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 11.74M | 14.19M | (8.22M) | 8.73M | (6.42M) |
| Other Working Capital | 87.22M | (48.92M) | (43.24M) | (12.36M) | 68.53M |
| Other Non-Cash Items | 79.37M | 136.98M | 95.74M | 95.54M | 37.95M |
| Operating Cash Flow | 694.28M | 443.67M | 490.81M | 615.42M | 812.86M |
| Capital Expenditures | (57.25M) | (54.39M) | (58.78M) | (85.24M) | (78.2M) |
| Acquisitions (Net) | (65.64M) | 17.8M | (20.17M) | 2.64M | (80.38M) |
| Purchases of Investments | 0 | 0 | 0 | (23.36M) | (350M) |
| Sales of Investments | 142K | 0 | 0 | 0 | 23.36M |
| Other Investing Activities | 0 | 0 | 0 | 0 | (10.27M) |
| Investing Cash Flow | (122.75M) | (36.59M) | (78.94M) | (105.96M) | (495.5M) |
| Debt Repayment | 49.04M | (245.86M) | (173.04M) | (58.65M) | 309.86M |
| Common Stock Issued | 35.05M | 27.75M | 39.49M | 17.22M | 17.51M |
| Common Stock Repurchased | (298.22M) | (214.08M) | (225.5M) | (252.67M) | (283.05M) |
| Dividends Paid | (80.48M) | (91.84M) | (100.01M) | (108.47M) | (117.75M) |
| Other Financing Activities | (38.28M) | (47.38M) | (23.93M) | (22.28M) | (33.38M) |
| Financing Cash Flow | (332.88M) | (571.4M) | (483M) | (424.85M) | (106.82M) |
| Effect of Forex Changes | (19.63M) | (88.37M) | 8.03M | (20.04M) | (4.96M) |
| Net Change in Cash | 219.02M | (252.69M) | (63.1M) | 64.58M | 205.59M |
| Free Cash Flow | 637.03M | 389.28M | 432.04M | 530.19M | 734.65M |
Genpact Limited
NYSE:G
Intrinsic Alpha fair value
Locked
Current Price
$41.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.